Exhaled carbon monoxide in patients with bronchiolitis obliterans after lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome Source: Eur Respir J 2005; 25: 813-819 Year: 2005
Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Changes in exhaled nitric oxide (eNO) over time in stable lung transplant recipients without chronic rejection Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003
Exhaled breath particles - a potential noninvasive method to detect and monitor chronic allograft dysfunction in lung transplant recipients Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Exhaled NO measurements may be useful in assessing acute lung injury in donors and lung allograft recipients Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007
Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003
Exhaled nitric oxide measured at different flow rates to detect early bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Exhaled volatile organic compounds as biomarkers for respiratory diseases Source: Eur Respir Monogr 2010; 49: 130-139 Year: 2010
Exhaled biomarkers in patients with cystic fibrosis and lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 267s Year: 2003
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Source: Eur Respir J 2002; 20: 92-99 Year: 2002
Infections increase exhaled nitric oxide, but not carbon monoxide levels in lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003
Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010
Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001
Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Carbon monoxide pollution is associated with decreased lung function in asthmatic adults Source: Eur Respir J 2010; 35: 266-272 Year: 2010